Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer

This study is ongoing, but not recruiting participants.

Study NCT00485485 Information provided by M.D. Anderson Cancer Center

First Received: June 12, 2007 Last Updated: January 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2009
Estimated Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)